Cargando…
Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib
Objective: The efficacy of anlotinib as a treatment for head-and-neck squamous cell carcinoma (HNSCC) has been little explored. Here, we used patient-derived xenografts (PDXs) to this end. Methods: Fresh tumor tissues of HNSCC patients were screened in terms of in vitro drug sensitivity using the MT...
Autores principales: | Hu, Fangling, Guo, Liang, Yu, Jieqing, Dai, Daofeng, Xiong, Yuanping, He, Yuanqiao, Zhou, Wensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696349/ https://www.ncbi.nlm.nih.gov/pubmed/34955687 http://dx.doi.org/10.3389/pore.2021.1610008 |
Ejemplares similares
-
Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer
por: Yang, Yong, et al.
Publicado: (2022) -
The characteristics of head and neck squamous cell cancer in young adults: A retrospective single-center study
por: Révész, Mónika, et al.
Publicado: (2023) -
GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma—Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis
por: Kawasaki, Yohei, et al.
Publicado: (2022) -
Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma
por: Jiang, Wenru, et al.
Publicado: (2023) -
SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma
por: Yang, Meng-Ling, et al.
Publicado: (2021)